Renasant Bank’s CME Group CME Stock Holding History

Renasant Bank’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$702K	Buy	3,180 +2,057	+183%	+$569K	0.45%	64
2026 Q1	$332K	Buy	1,123 +188	+20%	+$55.8K	0.23%	102
2025 Q4	$255K	Sell	935 -168	-15%	-$45.7K	0.17%	121
2025 Q3	$298K	Buy	+1,103	New	+$300K	0.19%	115

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Renasant Bank's CME Position: Q2 2026 in Review

Renasant Bank increased its CME Group (CME) stake by 183% in Q2 2026, buying an estimated $569K and bringing the position to 3,180 shares worth $702K. The position accounts for 0.45% of the portfolio, ranked #64.

Renasant Bank first reported a position in CME in Q3 2025 and has held it in 4 quarters since. 1,704 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Renasant Bank held 3,180 shares of CME Group worth $702K as of Q2 2026.
Renasant Bank bought 2,057 CME Group shares in Q2 2026, an estimated $569K.
CME Group made up 0.45% of Renasant Bank's portfolio in Q2 2026, its #64 holding.
Renasant Bank first reported a position in CME Group in Q3 2025 and has held it in 4 quarters since.
1,704 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Renasant Bank's 13F filing for Q2 2026, filed 11 Aug 2026.